Insights on the Stretch Marks Treatment Global Market to 2027 - Microdermabrasion Segment to Record 3.1% CAGR - ResearchAndMarkets.com

2023-01-13

DUBLIN--(BUSINESS WIRE)--The "Stretch Marks Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

'Stretch Marks Treatment: Global Strategic Business Report'

The global market for Stretch Marks Treatment estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027.

Topical Products, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lasers segment is readjusted to a revised 3.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $376.5 Million, While China is Forecast to Grow at 6.9% CAGR

The Stretch Marks Treatment market in the U.S. is estimated at US$376.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$386.2 Million by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 2.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$256.3 Million by the year 2027.

Microdermabrasion Segment to Record 3.1% CAGR

In the global Microdermabrasion segment, USA, Canada, Japan, China and Europe will drive the 3.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$93.6 Million in the year 2020 will reach a projected size of US$112.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 3.9% CAGR through the analysis period.

Select Competitors (Total 46 Featured) -

Basq Skincare

Clarins Group

Cynosure, Inc.

Dermaclara, Inc.

E.T. Browne Drug Co., Inc.

Ellipse, a Candela Company

Helix Biomedix, Inc.

Laboratoires Expanscience

Mama Mio US Inc.

Merz North America, Inc.

Syneron Medical Ltd.